Subscribe
A strategic review of the thermal products division is under way
The company鈥檚 shares sold off with the rest of the software sector, but its results were impressive
Energy costs have fallen as a percentage of sales 鈥� but for how much longer?
The group is undoing the damage in North America, but credibility may take some time to rebuild
The main market entrant aims to rebuild margins this year after a heavy investment push
The engineering group鈥檚 results show the benefits of its new focus after the sale of its aerostructures arm
The medical device decontamination business reported broad-based sales growth across all regions
The gene sequencing company is undergoing management change at a tense time for the market
The refractory company needs industrial spending to be strong all over the world, but steel, cement and glassmakers are not bullish
Management is guiding for 6 per cent growth in underlying revenues
